Your browser is no longer supported. Please, upgrade your browser.
LABU Direxion Daily S&P Biotech Bull 3X ETF daily Stock Chart
Direxion Daily S&P Biotech Bull 3X ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week11.36%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month7.39%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter40.40%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.40 Perf Half Y54.05%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year55.03%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range21.94 - 55.88 Perf YTD63.40%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-8.45% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low133.18% ATR2.62
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)62.34 Volatility4.58% 5.25%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.60 Prev Close49.84
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.03M Price51.16
Recom- SMA2012.07% SMA506.83% SMA20022.63% Volume1,205,321 Change2.65%
Apr-04-17 09:02AM  Healthcare Moves Have Been Muted, but Could We Get a Surprise?
Mar-20-17 12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs at MarketWatch
Feb-26-17 08:26PM  Zacks Podcast Highlights: How Do Leveraged and Inverse ETFs Work?
Feb-17-17 01:40PM  Biotech 2017: 4 Ideas for A Stockpicker's Year at
Jan-31-17 05:09PM  Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting +12.28%
01:08PM  Biotech Stocks Gain on Latest Trump Drug Price Statements
Jan-11-17 12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes -10.63%
Jan-04-17 10:56AM  Trying to Knock Out Some Individual Trades, but it Is not Easy +13.41%
Dec-08-16 10:34AM  How Will Trumps Take on the ACA Affect Healthcare Stocks?
Nov-15-16 10:47AM  6 Leveraged ETFs Soaring on Trump Rally
Nov-11-16 03:16PM  Biotech ETFs Unwind Political Risk After Trump Victory
Nov-08-16 09:34AM  Which Sectors to Invest in If Donald Trump Wins
Nov-01-16 11:20AM  Biotech Stocks Rise As Most Other Sectors Fall
Oct-21-16 09:54AM  Five Biotech ETFs Posting Strong Second-Halfs: From ALPS Medical Breakthroughs (SBIO) To The SPDR S&P Biotech ETF (XBI) at Insider Monkey
Oct-14-16 03:26PM  Can Biotech Stocks Stay Trendy? -8.90%
11:43AM  Seize ETF Tools To Position Your Portfolio For Any Election Outcome
Oct-04-16 12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) at Investopedia
Oct-03-16 10:58AM  5 Best Performing Leveraged ETFs of September
Sep-27-16 03:21PM  Loving LABU: A Leveraged Biotech ETF On A Torrid Pace
Aug-25-16 06:52AM  The Active Traders Guide To Hillary Clinton's Rhetoric
Aug-24-16 04:22PM  Ugly Underlying Action Should Stay Hidden -12.93%
Aug-08-16 05:09PM  How Volatility Affects 2 Popular Leveraged ETFs -5.76%
Aug-04-16 01:46PM  Biotech Rally Stokes Activity In Leveraged ETFs
Jul-19-16 02:39PM  Hot Spots Short-Term ETF Traders Are Targeting -5.45%
Jun-22-16 02:07PM  Traders Get It Right (Sort Of) With Leveraged Biotech ETFs
Jun-10-16 09:21AM  A Conservative Way To Short The S&P 500 -6.47%
Jun-07-16 12:33AM  Biotech Bounce: Sizzle Or Fizzle? -5.38%
May-27-16 01:11PM  This Biotech ETF Could Be Ready To Party
May-04-16 09:21PM  BIB vs. LABU: Comparing Leveraged Biotech ETFs at Investopedia -11.92%
Apr-19-16 07:10AM  Return Of The Mack: This Biotech ETF Is Back -5.66%
Apr-07-16 12:30PM  A Leader-Laggard Long-Short ETF Pair Trade
Apr-06-16 08:15AM  Inklings Of Upside For A Leveraged Biotech ETF +22.46%
Mar-22-16 05:00PM  Reminder: Direxion Announces Reverse and Forward Share Splits of Ten Leveraged ETFs PR Newswire +9.75%
Mar-08-16 09:00AM  Trader's Notebook: Is It Time to Short Netflix and Facebook? -15.87%
Mar-02-16 10:35AM  This Market Is 'Climbing the Wall of Worry' +12.44%
Feb-19-16 06:11PM  Direxion Announces Reverse and Forward Share Splits of Ten Leveraged ETFs PR Newswire
08:50AM  Some Traders Aren't Shy About Betting On A Biotech Rebound
Feb-04-16 10:48AM  Big Caps Signal a Rotation Taking Place +5.82%
Jan-22-16 07:11AM  Even With Volatility, Investors Love Biotech ETFs +8.64%
Jan-12-16 07:20AM  Betting On A Biotech Bounce With A Familiar ETF +8.84%
Dec-23-15 05:46AM  LABU: Direxion Daily S&P Biotech Bull 3X ETF at Investopedia
Dec-01-15 07:40AM  Another Visit With A Leveraged Biotech ETF
Oct-28-15 03:12PM  Traders Get Adventurous With Leveraged Biotech ETFs +8.14%
02:22PM  Is There A Bubble In Leveraged ETFs? at
Oct-24-15 05:37PM  Volatility Sparks Inflows To Inverse, Leveraged ETFs
Oct-02-15 02:53PM  Breaking Down Biotech ETFs With Leverage +14.68%
Sep-28-15 04:58PM  Capitulation In Biotech? ETF Suffers Biggest One-Day Drop Since 2011 at -22.74%
03:57PM  Wild Ride For Leveraged Biotech ETFs Continues
Sep-25-15 12:08PM  Guide to Inverse & Leveraged Biotech ETF Investing -20.53%
Sep-24-15 02:57PM  The 3 Key Factors in Biotech ETF Investing
Sep-23-15 10:48AM  Traders Bet Against Hillary With Leveraged Biotech ETF
Sep-22-15 02:34PM  Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet -6.57%
Sep-16-15 07:18AM  They're Heeere: Leveraged Cybersecurity ETFs
Aug-20-15 03:28PM  A Bad Sign For Biotech Bulls -16.26%
Aug-19-15 01:20PM  4 New Leveraged ETFs Right For The Times
Aug-07-15 02:31PM  A Bad Week For Biotech Was Great For This ETF -7.40%
Jul-15-15 08:20AM  Traders Bet on new Leveraged Biotech ETFs
Jun-23-15 12:30PM  More Triple-Leveraged Biotech ETFs Come to Town
09:00AM  Mess With the Leveraged Biotech Bull ETF and get the Horns
Jun-09-15 12:08PM  Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Jun-05-15 12:53PM  Preparing for Biotech ETF Retrenchment
Jun-02-15 08:00AM  New Leveraged Biotech ETF off to a Fast Start
May-28-15 11:47AM  Back in the Lab: Triple-Leveraged Biotech ETFs are Here
08:30AM  Direxion Investments Launches Four Leveraged ETFs for Active Traders PR Newswire
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.